Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

CYP2D6 Genotype-guided Metoprolol Therapy in Cardiac Surgery Patients: Rationale and Design of the Pharmacogenetic-guided Metoprolol Management for Postoperative Atrial Fibrillation in Cardiac Surgery (PREEMPTIVE) Pilot Study.

Dunham WC, Weinger MB, Slagle J, Pretorius M, Shah AS, Absi TS, Shotwell MS, Beller M, Thomas E, Vnencak-Jones CL, Freundlich RE, Wanderer JP, Sandberg WS, Kertai MD.

J Cardiothorac Vasc Anesth. 2019 Sep 10. pii: S1053-0770(19)30962-0. doi: 10.1053/j.jvca.2019.09.003. [Epub ahead of print]

PMID:
31606278
2.

Clinicopathologic correlates of MYD88 L265P mutation and programmed cell death (PD-1) pathway in primary central nervous system lymphoma.

Sethi TK, Kovach AE, Grover NS, Huang LC, Lee LA, Rubinstein SM, Wang Y, Morgan DS, Greer JP, Park SI, Ann Thompson-Arildsen M, Yenamandra A, Vnencak-Jones CL, Reddy NM.

Leuk Lymphoma. 2019 Jun 11:1-10. doi: 10.1080/10428194.2019.1620942. [Epub ahead of print]

PMID:
31184237
3.

The impact of variant classification on the clinical management of hereditary cancer syndromes.

Turner SA, Rao SK, Morgan RH, Vnencak-Jones CL, Wiesner GL.

Genet Med. 2019 Feb;21(2):426-430. doi: 10.1038/s41436-018-0063-z. Epub 2018 Jun 6.

PMID:
29875428
4.

Deciphering Elevated Microsatellite Alterations at Selected Tetra/Pentanucleotide Repeats, Microsatellite Instability, and Loss of Heterozygosity in Colorectal Cancers.

Wang Y, Vnencak-Jones CL, Cates JM, Shi C.

J Mol Diagn. 2018 May;20(3):366-372. doi: 10.1016/j.jmoldx.2018.02.001. Epub 2018 Feb 21.

5.

Clinical prognostic value of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in glioblastoma.

Mistry AM, Vnencak-Jones CL, Mobley BC.

J Neurooncol. 2018 Jun;138(2):307-313. doi: 10.1007/s11060-018-2796-6. Epub 2018 Feb 8.

PMID:
29423539
6.

Authors' Reply.

Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, Tsimberidou AM, Vnencak-Jones CL, Wolff DJ, Younes A, Nikiforova MN.

J Mol Diagn. 2018 Jan;20(1):125-126. doi: 10.1016/j.jmoldx.2017.11.002.

7.

Comparison of BCR/ABL1 mRNA levels by quantitative real-time PCR in peripheral blood and bone marrow specimens of patients with chronic myelogenous leukemia.

Thomas JS, Jagasia M, Vnencak-Jones CL.

Leuk Lymphoma. 2017 Sep;58(9):1-4. doi: 10.1080/10428194.2017.1287362. Epub 2017 Feb 14. No abstract available.

PMID:
28278720
8.

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.

Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, Tsimberidou AM, Vnencak-Jones CL, Wolff DJ, Younes A, Nikiforova MN.

J Mol Diagn. 2017 Jan;19(1):4-23. doi: 10.1016/j.jmoldx.2016.10.002. Review.

9.

Differences in Microsatellite Instability Profiles between Endometrioid and Colorectal Cancers: A Potential Cause for False-Negative Results?

Wang Y, Shi C, Eisenberg R, Vnencak-Jones CL.

J Mol Diagn. 2017 Jan;19(1):57-64. doi: 10.1016/j.jmoldx.2016.07.008. Epub 2016 Nov 1.

10.

Primary Carcinoid Tumor of the Renal Pelvis Arising From Intestinal Metaplasia: An Unusual Histogenetic Pathway?

Kuba MG, Wasserman A, Vnencak-Jones CL, Bridge JA, Gellert L, Hameed O, Giannico GA.

Appl Immunohistochem Mol Morphol. 2017 Aug;25(7):e49-e57. doi: 10.1097/PAI.0000000000000445.

PMID:
27753663
11.

Mutation profiles of synchronous colorectal cancers from a patient with Lynch syndrome suggest distinct oncogenic pathways.

Wheeler SR, Shi C, Holt JA, Vnencak-Jones CL.

J Gastrointest Oncol. 2016 Jun;7(3):E64-71. doi: 10.21037/jgo.2016.01.07.

12.

Characterization of breast cancers with PI3K mutations in an academic practice setting using SNaPshot profiling.

Abramson VG, Cooper Lloyd M, Ballinger T, Sanders ME, Du L, Lai D, Su Z, Mayer I, Levy M, LaFrance DR, Vnencak-Jones CL, Shyr Y, Dahlman KB, Pao W, Arteaga CL.

Breast Cancer Res Treat. 2014 Jun;145(2):389-99. doi: 10.1007/s10549-014-2945-3. Epub 2014 Apr 11.

13.

Endomyometriosis ("Uterus-like mass") in an XY Male: Case Report With Molecular Confirmation and Literature Review.

González RS, Vnencak-Jones CL, Shi C, Fadare O.

Int J Surg Pathol. 2014 Aug;22(5):421-6. doi: 10.1177/1066896913501385. Epub 2014 Mar 19.

PMID:
24651910
14.

Beyond histology: translating tumor genotypes into clinically effective targeted therapies.

Meador CB, Micheel CM, Levy MA, Lovly CM, Horn L, Warner JL, Johnson DB, Zhao Z, Anderson IA, Sosman JA, Vnencak-Jones CL, Dahlman KB, Pao W.

Clin Cancer Res. 2014 May 1;20(9):2264-75. doi: 10.1158/1078-0432.CCR-13-1591. Epub 2014 Mar 5. Review.

15.

BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition.

Hutchinson KE, Lipson D, Stephens PJ, Otto G, Lehmann BD, Lyle PL, Vnencak-Jones CL, Ross JS, Pietenpol JA, Sosman JA, Puzanov I, Miller VA, Pao W.

Clin Cancer Res. 2013 Dec 15;19(24):6696-702. doi: 10.1158/1078-0432.CCR-13-1746.

16.

Lymphoepithelioma-like carcinoma of the endometrium: immunophenotypic characterization of a rare tumor with microsatellite instability testing.

Jones H, Gold MA, Giannico G, Troutman A, Vnencak-Jones CL, Schultenover SJ, Fadare O.

Int J Gynecol Pathol. 2014 Jan;33(1):64-73. doi: 10.1097/PGP.0b013e318276310b.

PMID:
24300538
17.

Maternal FMR1 premutation allele expansion and contraction in fraternal twins.

Alfaro MP, Cohen M, Vnencak-Jones CL.

Am J Med Genet A. 2013 Oct;161A(10):2620-5. doi: 10.1002/ajmg.a.36123. Epub 2013 Aug 15.

PMID:
23949867
18.

Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing.

Cushman-Vokoun AM, Stover DG, Zhao Z, Koehler EA, Berlin JD, Vnencak-Jones CL.

Clin Colorectal Cancer. 2013 Sep;12(3):168-78. doi: 10.1016/j.clcc.2013.04.005. Epub 2013 Jun 14.

19.

Characteristics of lung cancers harboring NRAS mutations.

Ohashi K, Sequist LV, Arcila ME, Lovly CM, Chen X, Rudin CM, Moran T, Camidge DR, Vnencak-Jones CL, Berry L, Pan Y, Sasaki H, Engelman JA, Garon EB, Dubinett SM, Franklin WA, Riely GJ, Sos ML, Kris MG, Dias-Santagata D, Ladanyi M, Bunn PA Jr, Pao W.

Clin Cancer Res. 2013 May 1;19(9):2584-91. doi: 10.1158/1078-0432.CCR-12-3173. Epub 2013 Mar 20.

20.

BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors.

Dahlman KB, Xia J, Hutchinson K, Ng C, Hucks D, Jia P, Atefi M, Su Z, Branch S, Lyle PL, Hicks DJ, Bozon V, Glaspy JA, Rosen N, Solit DB, Netterville JL, Vnencak-Jones CL, Sosman JA, Ribas A, Zhao Z, Pao W.

Cancer Discov. 2012 Sep;2(9):791-7. Epub 2012 Jul 13.

21.

Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1.

Ohashi K, Sequist LV, Arcila ME, Moran T, Chmielecki J, Lin YL, Pan Y, Wang L, de Stanchina E, Shien K, Aoe K, Toyooka S, Kiura K, Fernandez-Cuesta L, Fidias P, Yang JC, Miller VA, Riely GJ, Kris MG, Engelman JA, Vnencak-Jones CL, Dias-Santagata D, Ladanyi M, Pao W.

Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):E2127-33. doi: 10.1073/pnas.1203530109. Epub 2012 Jul 6.

22.

Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers.

Sengsayadeth SM, Jagasia M, Engelhardt BG, Kassim A, Strickland SA, Goodman S, Lucid C, Vnencak-Jones CL, Greer JP, Savani BN.

Bone Marrow Transplant. 2012 Dec;47(12):1535-7. doi: 10.1038/bmt.2012.88. Epub 2012 Jun 4.

PMID:
22659680
23.

Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.

Pulley JM, Denny JC, Peterson JF, Bernard GR, Vnencak-Jones CL, Ramirez AH, Delaney JT, Bowton E, Brothers K, Johnson K, Crawford DC, Schildcrout J, Masys DR, Dilks HH, Wilke RA, Clayton EW, Shultz E, Laposata M, McPherson J, Jirjis JN, Roden DM.

Clin Pharmacol Ther. 2012 Jul;92(1):87-95. doi: 10.1038/clpt.2011.371. Epub 2012 May 16.

24.

Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials.

Lovly CM, Dahlman KB, Fohn LE, Su Z, Dias-Santagata D, Hicks DJ, Hucks D, Berry E, Terry C, Duke M, Su Y, Sobolik-Delmaire T, Richmond A, Kelley MC, Vnencak-Jones CL, Iafrate AJ, Sosman J, Pao W.

PLoS One. 2012;7(4):e35309. doi: 10.1371/journal.pone.0035309. Epub 2012 Apr 20.

25.

A comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnel.

Goins WP, Edwards KM, Vnencak-Jones CL, Rock MT, Swift M, Thayer V, Schaffner W, Talbot TR.

Clin Infect Dis. 2012 Apr;54(7):938-45. doi: 10.1093/cid/cir973. Epub 2012 Jan 11.

26.

A platform for rapid detection of multiple oncogenic mutations with relevance to targeted therapy in non-small-cell lung cancer.

Su Z, Dias-Santagata D, Duke M, Hutchinson K, Lin YL, Borger DR, Chung CH, Massion PP, Vnencak-Jones CL, Iafrate AJ, Pao W.

J Mol Diagn. 2011 Jan;13(1):74-84. doi: 10.1016/j.jmoldx.2010.11.010. Epub 2010 Dec 23.

27.

A novel BMPR2 mutation associated with pulmonary arterial hypertension in an octogenarian.

Johri S, Dunnington GH, Vnencak-Jones CL.

Lung. 2010 Aug;188(4):349-52. doi: 10.1007/s00408-010-9242-7. Epub 2010 May 23.

28.

Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial.

Hiremath J, Thanikachalam S, Parikh K, Shanmugasundaram S, Bangera S, Shapiro L, Pott GB, Vnencak-Jones CL, Arneson C, Wade M, White RJ; TRUST Study Group.

J Heart Lung Transplant. 2010 Feb;29(2):137-49. doi: 10.1016/j.healun.2009.09.005.

PMID:
20022264
29.

T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension.

Austin ED, Rock MT, Mosse CA, Vnencak-Jones CL, Yoder SM, Robbins IM, Loyd JE, Meyrick BO.

Respir Med. 2010 Mar;104(3):454-62. doi: 10.1016/j.rmed.2009.10.004. Epub 2009 Oct 31.

30.

Competency-based education for the molecular genetic pathology fellow: a report of the association for molecular pathology training and education committee.

Talbert ML, Dunn ST, Hunt J, Hillyard DR, Mirza I, Nowak JA, Van Deerlin V, Vnencak-Jones CL.

J Mol Diagn. 2009 Nov;11(6):497-507. doi: 10.2353/jmoldx.2009.090040. Epub 2009 Oct 1.

31.

A B-cell lymphoma diagnosed in "floater" tissue: implications of the diagnosis and resolution of a laboratory error.

Mosse CA, Stumph JR, Best DH, Vnencak-Jones CL.

Am J Med Sci. 2009 Sep;338(3):248-51. doi: 10.1097/MAJ.0b013e3181a88dc0.

PMID:
19745614
32.

Bone marrow engraftment studies.

Vnencak-Jones CL.

Curr Protoc Hum Genet. 2009 Jul;Chapter 9:Unit 9.17. doi: 10.1002/0471142905.hg0917s62.

PMID:
19582766
33.

Copy-number variation in BMPR2 is not associated with the pathogenesis of pulmonary arterial hypertension.

Johnson JA, Vnencak-Jones CL, Cogan JD, Loyd JE, West J.

BMC Med Genet. 2009 Jun 16;10:58. doi: 10.1186/1471-2350-10-58.

34.

Bone marrow engraftment studies.

Vnencak-Jones CL.

Curr Protoc Hum Genet. 2004 Nov;Chapter 9:Unit9.17. doi: 10.1002/0471142905.hg0917s43.

PMID:
18428367
35.

Microsatellite stable genome in an epithelioid hemangioendothelioma: An example of a microsatellite stable tumor.

Boyd AS, Vnencak-Jones CL, Pennington B.

J Am Acad Dermatol. 2008 Mar;58(3):519-21. doi: 10.1016/j.jaad.2006.06.013. No abstract available.

PMID:
18280360
36.

PRNP M129V homozygosity in multiple system atrophy vs. Parkinson's disease.

Shibao C, Garland EM, Gamboa A, Vnencak-Jones CL, Van Woeltz M, Haines JL, Yu C, Biaggioni I.

Clin Auton Res. 2008 Feb;18(1):13-9. doi: 10.1007/s10286-007-0447-7. Epub 2008 Jan 30.

PMID:
18236005
37.

Comparison of peripheral blood and bone marrow samples for detection of post transplant mixed chimerism.

Stumph J, Vnencak-Jones CL, Koyama T, Frangoul H.

Bone Marrow Transplant. 2008 Mar;41(6):589-90. Epub 2007 Nov 26. No abstract available.

PMID:
18037938
38.

Bad nature, bad nurture, and testimony regarding MAOA and SLC6A4 genotyping at murder trials.

Bernet W, Vnencak-Jones CL, Farahany N, Montgomery SA.

J Forensic Sci. 2007 Nov;52(6):1362-71. Epub 2007 Oct 17.

PMID:
17944904
39.

Cutaneous epithelioid angiomatous nodule: report of a case and absence of microsatellite instability.

Kantrow S, Martin JD, Vnencak-Jones CL, Boyd AS.

J Cutan Pathol. 2007 Jun;34(6):515-6. No abstract available.

PMID:
17518784
40.

Identification of molecular biomarkers for multiple sclerosis.

Fossey SC, Vnencak-Jones CL, Olsen NJ, Sriram S, Garrison G, Deng X, Crooke PS 3rd, Aune TM.

J Mol Diagn. 2007 Apr;9(2):197-204.

41.

Bartonella henselae endocarditis in a child.

Pitchford CW, Creech CB 2nd, Peters TR, Vnencak-Jones CL.

Pediatr Cardiol. 2006 Nov-Dec;27(6):769-71. Epub 2006 Nov 16.

PMID:
17111290
42.

Mobilization of Ph chromosome-negative peripheral blood stem cells in a child with chronic myeloid leukemia after imatinib-induced complete molecular remission.

Woods-Swafford W, Vnencak-Jones CL, Loken MR, Manes B, Frangoul H.

Pediatr Blood Cancer. 2008 Mar;50(3):639-41.

PMID:
16927371
43.

Use of short tandem repeats for DNA fingerprinting to rapidly diagnose graft-versus-host disease in solid organ transplant patients.

Schrager JJ, Vnencak-Jones CL, Graber SE, Neff AT, Chari RS, Wright KJ Jr, Pinson CW, Stewart JH, Gorden DL.

Transplantation. 2006 Jan 15;81(1):21-5.

PMID:
16421472
44.

BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays?

Fossey SC, Ferreira-Gonzalez A, Garrett CT, Dumur CI, Vnencak-Jones CL.

Mol Diagn. 2005;9(4):187-93.

PMID:
16392897
45.

Subcutaneous panniculitic T-cell lymphoma in a cardiac allograft recipient.

Bregman SG, Yeaney GA, Greig BW, Vnencak-Jones CL, Hamilton KS.

J Cutan Pathol. 2005 May;32(5):366-70.

PMID:
15811123
46.

Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension.

Cogan JD, Vnencak-Jones CL, Phillips JA 3rd, Lane KB, Wheeler LA, Robbins IM, Garrison G, Hedges LK, Loyd JE.

Genet Med. 2005 Mar;7(3):169-74.

PMID:
15775752
47.

Fragile X gene premutation in multiple system atrophy.

Garland EM, Vnencak-Jones CL, Biaggioni I, Davis TL, Montine TJ, Robertson D.

J Neurol Sci. 2004 Dec 15;227(1):115-8.

PMID:
15546601
48.

Molecular genetic and proteomic analysis of synchronous malignant gliomas.

Zhuang Z, Lee YS, Zeng W, Furuta M, Valyi-Nagy T, Johnson MD, Vnencak-Jones CL, Woltjer RL, Weil RJ.

Neurology. 2004 Jun 22;62(12):2316-9.

PMID:
15210906
49.

Androgen receptor CAG repeat lengths in ductal carcinoma in situ of breast, longest in apocrine variety.

Kasami M, Gobbi H, Dupont WD, Simpson JF, Page DL, Vnencak-Jones CL.

Breast. 2000 Feb;9(1):23-7.

50.

Allelic losses in oligodendroglial and oligodendroglioma-like neoplasms: analysis using microsatellite repeats and polymerase chain reaction.

Johnson MD, Vnencak-Jones CL, Toms SA, Moots PM, Weil R.

Arch Pathol Lab Med. 2003 Dec;127(12):1573-9.

PMID:
14632576

Supplemental Content

Loading ...
Support Center